PNR are delighted to announce the MHRA approval of our new facility in Blaenau Gwent, South Wales. We hold MIA, MIA(IMP), MS and WDA licences which allow us to expand…
Learn More
We are delighted to welcome Tony Pinney to PNR Pharma as Qualified Person. Tony has over 30 years’ experience within the Pharmaceutical Industry with various roles within Quality. After qualifying as a QP…
Learn More
To mark 75 years of the NHS, PNR Pharma was part of the Blaenau Gwent celebration and received a copy of the Nathan Wyburn artwork that was commissioned as part of…
Learn More
We are very pleased to announce that GRGC, a specialist research, communications and business development consultancy, are working with us to support our growth. Ray Collia, one of GRGC’s co-founders,…
Learn More
With Annex 1 implementation date fast approaching we are really pleased to announce that Di Morris and Pam Turner are discussion panellists in the PHSS Sterile product manufacturing conference & Aseptic Processing workshop 2023….
Learn More
We are delighted to welcome Di Morris to PNR Pharma as Qualified Person / QA Compliance Advisor. Di has worked in the pharmaceutical industry for over 40 years including in the areas…
Learn More
Please see this post from the Medicines and Healthcare products Regulatory Agency We’re working with support from partners to make it faster and easier to gain approval and to run…
Learn More
PNR Pharma will be exhibiting at “Advanced Therapies 2023” London, Excel 14-15 March. Pam Turner and Sarah Coram will be happy to answer your questions on EU/ UK clinical trials, commercialisation and commercial supplies….
Learn More
See this post from the EMA: Just published: Q&A on the interoperability of biosimilar medicines in the European Union. This Q&A responds to questions raised by the publication of a…
Learn More
We are delighted to welcome Aldyth Smith to PNR Pharma as Head of Supply Chain Aldyth brings with her over 28 years’ experience in the pharmaceutical industry encompassing Supply Chain , Logistics…
Learn MoreWe will email you to start the conversation